China Unveils New Rules on Biotech After Gene-Editing Scandal

February 27, 2019

(STAT News) – China has unveiled draft regulations on gene editing and other potentially risky biomedical technologies after a Chinese scientist’s claim of helping to create gene-edited babies roiled the global science community. Under the proposed measures, technology involving gene editing, gene transfer, and gene regulation would be categorized as “high-risk” and managed by the health department of the State Council, China’s Cabinet.

Recommended Reading